Volume 15, Number 5—May 2009
Methicillin-Resistant Staphylococcus aureus ST398 from Human Patients, Upper Austria
Methicillin-resistant Staphylococcus aureus (MRSA) clonal type ST398 is usually associated with animals. We examined 1,098 confirmed MRSA samples from human patients and found that 21 were MRSA ST398. Most (16) patients were farmers. Increasing prevalence from 1.3% (2006) to 2.5% (2008) shows emergence of MRSA ST398 in humans in Austria.
In the past few years, interest has focused on the emergence of methicillin-resistant Staphylococcus aureus (MRSA) in animals and the potential for cross-transmission between humans and animals (1). MRSA isolates that are strongly associated with pigs or contact with pigs show at least 2 similarities: they are not typeable by pulsed-field gel electrophoresis (PFGE) because their DNA cannot be digested by the restriction enzyme SmaI (2), and most belong to the MRSA clonal lineage sequence type (ST) 398 (1).
From January 2006 through May 2008, a total of 21 laboratories and/or hospitals in Upper Austria (project MRSA-Registry Upper Austria) sent us 1,210 suspected MRSA primary isolates consecutively collected from human patients. For quality control, all isolates were cultured and investigated for mecA/femA by PCR at the Austrian National Reference Centre (3). Of the 1,210 isolates, 1,098 (90.7%) were confirmed to be MRSA; the other 112 (9.3%) were either methicillin-sensitive S. aureus or were not S. aureus and therefore were excluded from the MRSA registry.
Most molecular biological investigations (DNA isolation, detection of the Panton-Valentine leukocidin [PVL] genes lukS-lukF, PFGE, spa typing) were performed as described (3). Determination of staphylococcal cassette chromosome mec (SCCmec) subtypes was performed by PCR according to Boye et al. (4). Multilocus sequence typing (MLST) PCR was performed according to Enright et al. (5). Sequence reactions were conducted by using BigDye fluorescent terminators (Applied Biosystems, Foster City, CA, USA). Sequencing was performed on the ABI PRISM 310 Genetic Analyzer (Applied Biosystems). Sequence types were assigned according to the S. aureus MLST database with use of the typing software at www.mlst.net (6).
Etest showed resistance patterns of the MRSA ST398 isolates to the following antimicrobial agents: ciprofloxacin, clindamycin, erythromycin, fosfomycin, fusidic acid, gentamicin, moxifloxacin, mupirocin, rifampin, and vancomycin. Resistance to doxycycline was determined by using the disk diffusion test. Data were interpreted according to the guidelines of the Clinical and Laboratory Standards Institute antimicrobial susceptibility testing standards, where available.
Demographic information and data from patient histories were systematically collected by using standardized questionnaires and were interpreted by physicians and infection control teams in hospitals as well as by physicians working in outpatient care. Infection and colonization were differentiated according to definitions from the Centers for Disease Control and Prevention (7) and interpreted by a physician.
Of the 1,098 primary MRSA isolates, 21 could not be digested by the restriction enzyme SmaI and were therefore investigated further (Table). All 21 patients (14 male, 7 female; median age 58 years, range 1–83 years) harbored MRSA of clonal lineage ST398. Although MRSA ST398 is suspected of being able to acquire virulence factor genes (1), only 5 patients were infected, whereas 15 were colonized. Status was unknown for 1. Of the 15 colonization cases, 12 were detected by screening. Regarding the infections, 4 cases were of minor clinical relevance, but 1 case (isolate no. 3332) showed progression of major clinical relevance: a 64-year-old pig farmer had received a prosthetic knee, and postoperative joint empyema with MRSA ST398 developed soon afterwards.
The first MRSA isolates in which ST398 was detected were collected in France during 1996–2002 (8). However, most publications concerning MRSA ST398 refer to samples collected since 2004 (9–11). In our institute, the first isolate belonging to ST398 was detected in January 2006, although we have investigated 2,657 MRSA isolates from persons all over Austria since 1996. Therefore, we assume that the emergence of MRSA ST398 in Austria is rather recent. Until now, this MRSA strain seemed to be restricted to Upper Austria, although pig farming is equally common in Lower Austria and in Styria. It might be interesting to investigate the reason for the varying prevalence of MRSA ST398 in different regions of Austria.
Our results correspond well with published data. SCCmec type V was predominant in our isolates, as has been found in Germany (9). One isolate harbored SCCmec type IV, but no type III, as has been reported in the Netherlands (12). None of our isolates harbored PVL genes, which confirms that the lukF/lukS genes are not necessarily present in community-acquired MRSA. Apparently, some community-acquired MRSA types (e.g., ST30, ST80, ST152) are PVL positive in most cases, whereas others (e.g., ST398) are not. However, although all the MRSA ST398 isolates found in Europe to date were PVL negative, a PVL-positive MRSA ST398 strain was recently detected in China (13).
The spa types among our isolates were t011, t034 (both commonly found in ST398), and t2346. They are closely related to each other as well as to other types belonging to ST398.
Antimicrobial drug–susceptibility testing showed that 19 of 21 isolates were resistant to doxycyline, 9 of which were also resistant to clindamycin and erythromycin. All isolates were susceptible to the other drugs tested. Only 2 isolates were fully susceptible to all agents tested. These antimicrobial drug–resistance profiles might reflect the frequent use of tetracyclines in veterinary medicine; in Austria, two thirds of all antimicrobial drugs used in veterinary practice, especially in pig and poultry farming, are tetracycline derivatives (14), a situation similar to that in other European countries (11,12). Therefore, it is not surprising that our resistance profiles correspond well with those from the Netherlands, Germany, and France (9,12,15).
The only isolate harboring spa type t034 was also the only isolate harboring SCCmec IV and is 1 of the 2 isolates that were fully susceptible to all antimicrobial drugs tested. Among all MRSA isolates, the percentage of ST398 in Upper Austria was 1.3% (6/463) in 2006, 2.3% (9/392) in 2007, and 2.5% (6/243) in 2008 (January–May). These percentages agree with data from Witte et al., who reported that MRSA ST398 is not frequent among S. aureus in Germany or the United Kingdom (9). However, the proportion of MRSA isolates that are ST398 has slightly increased in Upper Austria.
Most patients discussed in this article had had contact with animals. MRSA ST398 is known to be associated with animal contact, especially with pigs and cows (8–10,12). In the Netherlands and in France, the MRSA carriage rate is substantially higher for pig farmers and veterinarians than for the general population (11,15). In our study, 10 patients were pig farmers or direct relatives of pig farmers, and 6 were farmers (raised hens or unknown animal species). The animal contact status of 2 was unknown. In 2008, 3 of our patients had no direct animal contact; possible MRSA transmission from healthcare workers or other sources was not investigated. Thus, the question arises as to whether these isolates might represent more spread of this sequence type strain outside pig farms.
MRSA of clonal lineage ST398 has emerged in humans in Austria. Moreover, it is not confined to Europe but has also been detected in China (13), Thailand, and Canada (11). This finding indicates a great potential for spread, quantitatively as well as geographically. Because the international meat and livestock market is active, the stage is set for rapid spread. In addition, the largest exporter of live pigs in Europe is the Netherlands, and up to 39% of pigs from the Netherlands carry MRSA in their nares (12). Thus, we suggest intensified establishment of collaborations between laboratories from different countries.
Dr Krziwanek is a molecular biologist in the Austrian National Reference Centre for Nosocomial Infections and Antibiotic Resistance, Department of Hygiene, Microbiology and Tropical Medicine, Elisabethinen Hospital Linz. Her primary research interest is the epidemiology of S. aureus, in particular MRSA.
We thank our colleagues in the hospitals of Upper Austria, especially the infection control and laboratory teams, who participated in the MRSA-Registry Upper Austria project and thereby enabled this study.
This work was partly supported by a grant from the provincial government of Upper Austria (reference no. San-121654/16-2006-Hi/Shn).
- van Belkum A, Melles DC, Peeters JK, van Leeuwen WB, van Duijkeren E, Huijsdens XW, Methicillin-resistant and -susceptible Staphylococcus aureus sequence type 398 in pigs and humans. Emerg Infect Dis. 2008;14:479–83.
- Bens CC, Voss A, Klaassen CH. Presence of a novel DNA methylation enzyme in methicillin-resistant Staphylococcus aureus isolates associated with pig farming leads to uninterpretable results in standard pulsed-field gel electrophoresis analysis. J Clin Microbiol. 2006;44:1875–6.
- Krziwanek K, Luger C, Sammer B, Stumvoll S, Stammler M, Sagel U, MRSA in Austria—an overview. Clin Microbiol Infect. 2008;14:250–9.
- Boye K, Bartels MD, Andersen IS, Møller JA, Westh H. A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I–V. Clin Microbiol Infect. 2007;13:725–7.
- Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol. 2000;38:1008–15.
- Enright M. MLST Staphylococcus aureus database [database on the Internet]. Bath (UK): University of Bath; 2005 [cited 2008 Feb 28]. Available from http://www.mlst.net
- National Reference Centre for Surveillance of Nosocomial Infections, Robert Koch Institute, Berlin. Definitions of nosocomial infections (CDC definitions), 4th ed. [in German]. Berlin: Robert Koch Institute; 2003;1–48.
- Armand-Lefevre L, Ruimy R, Andremont A. Clonal comparison of Staphylococcus aureus isolates from healthy pig farmers, human controls, and pigs. Emerg Infect Dis. 2005;11:711–4.
- Witte W, Strommenger B, Stanek C, Cuny C. Methicillin-resistant Staphylococcus aureus ST398 in humans and animals, Central Europe. Emerg Infect Dis. 2007;13:255–8.
- Guardabassi L, Stegger M, Skov R. Retrospective detection of methicillin resistant and susceptible Staphylococcus aureus ST398 in Danish slaughter pigs. Vet Microbiol. 2007;122:384–6.
- Wulf MW, Sørum M, van Nes A, Skov R, Melchers WJ, Klaassen CH, Prevalence of methicillin-resistant Staphylococcus aureus among veterinarians: an international study. Clin Microbiol Infect. 2008;14:29–34.
- de Neeling AJ, van den Broek MJ, Spalburg EC, van Santen-Verheuvel MG, Dam-Deisz WD, Boshuizen HC, High prevalence of methicillin resistant Staphylococcus aureus in pigs. Vet Microbiol. 2007;122:366–72.
- Yu F, Chen Z, Liu C, Zhang X, Lin X, Chi S, Prevalence of Staphylococcus aureus carrying Panton-Valentine leukocidin genes among isolates from hospitalised patients in China. Clin Microbiol Infect. 2008;14:381–4.
- Federal Environment Agency Austria, ed. Veterinaerantibiotika in Wirtschaftsduenger und Boden [monograph on the Internet]. Vienna (Austria): Umweltbundesamt GmbH; 2005 [cited 2008 Feb 28]. Available from http://www.umweltbundesamt.at/fileadmin/site/publikationen/BE272.pdf
- Aubry-Damon H, Grenet K, Sall-Ndiaye P, Che D, Cordeiro E, Bougnoux ME, Antimicrobial resistance in commensal flora of pig farmers. Emerg Infect Dis. 2004;10:873–9.
Suggested citation for this article: Krziwanek K, Metz-Gercek S, Mittermayer H. Methicillin-resistant Staphylococcus aureus ST398 from human patients, Upper Austria. Emerg Infect Dis [serial on the Internet]. 2009 May [date cited]. Available from http://wwwnc.cdc.gov/eid/article/15/5/08-0326
Please use the form below to submit correspondence to the authors or contact them at the following address:
Karina Krziwanek, National Reference Centre for Nosocomial Infections and Antibiotic Resistance, Department of Hygiene, Microbiology and Tropical Medicine, Elisabethinen Hospital Linz, Fadingerstrasse 1, A-4010 Linz, Austria
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 16, 2010
- Page last updated: December 16, 2010
- Page last reviewed: December 16, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)